Equus Innovations, a manufacturer of advanced, next-generation veterinary regenerative products, in partnership with AlphaLogix, LLC (Argyle, Texas) announced today successful market release of a new canine allograft, AlphaFlo®.
Back to all posts
News | Press Release
AlphaLogix announces market release of AlphaFlo® canine allograft
You may want to read these articles
What’s the Difference Between RenoVō® and PRGF?
Equine regenerative medicine is evolving quickly, and with that comes more choices. Two options you may be using or evaluating are PRGF (Plasma Rich in Growth Factors) and RenoVō®, an acellular equine amniotic tissue allograft. While both are used to support tissue,...
RenoVō® vs. Alpha2EQ®: Comparing Equine Regenerative Options for Veterinary Use
As equine regenerative therapy evolves, veterinarians have more tools available to support tissue health. Two such products, RenoVō® and Alpha2EQ®, offer distinct biological compositions and clinical utility. Understanding their differences helps equine practitioners...